Status:
UNKNOWN
Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Amphetamine-Related Disorders
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
Detailed Description
This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripipra...
Eligibility Criteria
Inclusion
- Must meet DSM-4 criteria for methamphetamine abuse or dependence and are non-treatment seeking.
- Ability to verbalize understanding of the consent form, able to provide written informed consent, and verbalize willingness to complete study procedures.
Exclusion
- Please contact the site for more information.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00089440
Start Date
June 1 2004
End Date
March 1 2005
Last Update
January 11 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Integrated Substance Abuse Program
Los Angeles, California, United States, 90024
2
New York University, School of Medicine
New York, New York, United States, 10016